Results of study to increase liver size by embolisation in patients of liver surgery.
Not Applicable
- Conditions
- Health Condition 1: null- Patients with hepatobiliary malignancies with insufficient liver volumes before liver resection
- Registration Number
- CTRI/2016/04/006794
- Lead Sponsor
- one
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Patients with resectable hepatobiliary malignancies
requiring liver resection but with insufficient FLR.
2. Patients willing to undergo the procedure.
Exclusion Criteria
Patients with contraindications for PVE (Overt
clinical portal hypertension -thrombocytopenia,
oesophageal varices, splenomegaly, tumour invading
the portal vein, extrahepatic metastatic disease,
uncorrectable coagulopathy, a tumour precluding
safe transhepatic access, contraindications to liver
resection such as ASA grade IV status).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To assess the proportion of liver hypertrophy following PVE.Timepoint: 1. To assess the proportion of liver hypertrophy following PVE.
- Secondary Outcome Measures
Name Time Method 1. To study the feasibility of PVE in terms of of technical success rate. <br/ ><br>2. To study the periprocedural complications associated with PVE. <br/ ><br>3. To study the impact of PVE in terms of derangement of liver function tests, progression of the disease in waiting the period, and difficulties encountered during surgery. <br/ ><br>4. To study the overall success rate of PVE in terms of percentage of patients who underwent planned hepatic resection. <br/ ><br>Timepoint: On follow up